Sanofi
SAN
Real-time Euronext Paris - 09/20 05:35:02 pm
74.67EUR
-0.6%
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 20172018
Sales35 05535 107
EBITDA-10 977
Operating profit (EBIT)8 3998 381
Pre-Tax Profit (EBT)5 5305 588
Net income8 4345 005
EPS ( € )6,714,12
Dividend per Share ( € )3,033,07
Yield4,22%4,09%
Announcement Date02/07/2018
06:36am
-
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 20172018
Debt5 28616 227
Finance--
Operating income (EBITDA)-10 977
Leverage
(Debt/EBITDA)
-1,48x
Capital Expenditure-2 229
Book Value Per Share (BVPS)46,5 €47,0 €
Cash Flow per Share-6,14 €
Announcement Date02/07/2018
06:36am
-
Balance Sheet Analysis
Financial Ratios
Size 2018e 2019e
Capitalization 94 023 M€ -
Entreprise Value (EV) 110 250 M€ 109 297 M€
Valuation 2018e 2019e
P/E ratio (Price / EPS) 18,2x 16,9x
Capitalization / Revenue 2,68x 2,61x
EV / Revenue 3,14x 3,03x
EV / EBITDA 10,0x 9,56x
Yield (DPS / Price) 4,09% 4,21%
Price to book (Price / BVPS) 1,60x 1,59x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 23,9% 24,4%
operating Leverage (Delta EBIT / Delta Sales) - 1,79x
Net Margin (Net Profit / Revenue) 14,3% 14,9%
ROA (Net Profit / Asset) 6,13% 6,45%
ROE (Net Profit / Equities) 11,2% 12,1%
Rate of Dividend 74,6% 71,3%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   6,35% 4,16%
Cash Flow / Sales 21,8% 23,0%
Capital Intensity (Assets / Sales) 2,33x 2,30x
Financial Leverage (Net Debt / EBITDA) 1,48x 1,34x
Price Earning Ratio
BNA & Dividende